Comparison of Antibody Monitoring System with Flow Cytometric Crossmatch Test in Renal Transplant Recipients with High Panel-Reactive Antibody

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nephron Clinical Practice

• Publication date

  2009-03-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000209153PMID 19293595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.

  2008cited by this paper
• Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.

  2007cited by this paper
• Renal Transplantation in Patients With Pre‐Transplant Donor‐Specific Antibodies and Negative Flow Cytometry Crossmatches

  2007cited by this paper
• Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.

  2007cited by this paper
• Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.

  2006cited by this paper
• Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.

  2006cited by this paper
• Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

  2005cited by this paper
• Significance of donor-specific antibodies in acute rejection.

  2005cited by this paper
• Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.

  2004cited by this paper
• Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1

  2003cited by this paper
• Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients.

  2003cited by this paper
• Pre‐Transplant Assessment of Donor‐Reactive, HLA‐Specific Antibodies in Renal Transplantation: Contraindication vs. Risk

  2003cited by this paper
• Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival.

  2003cited by this paper
• Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.

  2001cited by this paper
• IMPACT OF DONOR-SPECIFIC ANTIBODIES ON CHRONIC REJECTION OCCURRENCE AND GRAFT LOSS IN RENAL TRANSPLANTATION: POSTTRANSPLANT ANALYSIS USING FLOW CYTOMETRIC TECHNIQUES1

  2001cited by this paper
• Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation

  2000cited by this paper
• Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients.

  1991cited by this paper

• Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory

  2017cites this paper
• A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.

  2012cites this paper
• Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection.

  2012cites this paper
• B-cell Complement Dependent Cytotoxic Crossmatch Positivity is an Independent Risk Factor for Long-term Renal Allograft Survival

  2011cites this paper